Theranos Had $200 Million in Cash Left at Year-End

The embattled blood-diagnostics firm had $200 million of cash on hand at the end of 2016, people familiar with the matter said, less than a quarter of the funding it raised from investors and partners.
http://on.wsj.com/2lTyyEl